Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Warning! 3 Stocks That Are Waving Big Red Flags
04:03pm, Sunday, 14'th May 2023
The current recovery in the stock market has been uneven. Tech is booming, financials are lagging and everything in between is a mixed bag.
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
02:00pm, Thursday, 11'th May 2023
Investors will love Johnson & Johnson's commitment to dividend payments. Vertex Pharmaceuticals already delivers billion-dollar earnings -- and new programs could further lift growth.
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer
10:23am, Thursday, 11'th May 2023
The global RSV vaccine market isn't all that big, and healthcare giants are battling for market share. Potential vaccines from Pfizer and Moderna have demonstrated high efficacy in late-stage trials.
As COVID public health emergency ends, ‘whack-a-mole' virus won't be easy to track
02:30pm, Wednesday, 10'th May 2023
As the U.S. COVID-19 public health emergency comes to an end on Thursday, the fight against COVID goes on–-and some new challenges begin for those who hope to keep the virus at bay.
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
10:43am, Tuesday, 09'th May 2023
Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market
09:16am, Tuesday, 09'th May 2023
Moderna's next big moment may come at the start of 2023's fall vaccination season. The vaccine giant's infrastructure and supply chain are ready -- and it says its discussions with commercial buyers h
Is Moderna a Value Stock to Buy Right Now?
03:13pm, Sunday, 07'th May 2023
Moderna doesn't look like a value stock right now. With a big potential for its COVID-19, flu, and RSV vaccines, though, it could look like a bargain in retrospect.
Is Moderna Building a Respiratory Vaccine Empire?
05:30am, Saturday, 06'th May 2023
Moderna's coronavirus vaccine revenue is declining -- but it still should remain at blockbuster levels. And the company has big plans beyond the coronavirus vaccine that could bring enormous rewards b
Moderna stock closes higher on earnings beat, unexpected profit
05:16pm, Thursday, 04'th May 2023
Yahoo Finance Live anchors Akiko Fujita and Seana Smith discuss a rise in shares of Moderna as the company's Q1 earnings beat exceeded investor expectations.
Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%
03:12pm, Thursday, 04'th May 2023
Moderna MRNA reported earnings of 19 cents per share for the first quarter of 2023, beating the Zacks Consensus Estimate and our model estimate of a loss of $1.77 and $2.09, respectively. Earnings dec
COVID-19 ‘is not leaving the planet,' Moderna CEO says
02:59pm, Thursday, 04'th May 2023
Moderna Therapeutics CEO Stéphane Bancel joins Yahoo Finance Live to discuss first-quarter earnings, COVID-19 vaccine sales, profit growth, and the outlook for the biotechnology company's RSV vaccine
Moderna stock rises on Q1 earnings, positive vaccine guidance
02:37pm, Thursday, 04'th May 2023
Yahoo Finance Live's Rachelle Akuffo and Brad Smith discuss the rise in stock for Moderna following first-quarter earnings.
Moderna gets shot in the arm from unexpected 1Q profit, COVID vaccine sales outlook
10:28am, Thursday, 04'th May 2023
Moderna shares rose after the biotechnology company unexpectedly reported a profit for the first quarter and reaffirmed its 2023 COVID-19 vaccine sales expectations. The company posted earnings per
Moderna CEO Stéphane Bancel on surprise Q1 profit, post-Covid future
09:23am, Thursday, 04'th May 2023
Moderna CEO Stéphane Bancel joins 'Squawk Box' to discuss the company's quarterly earnings results, what's next for the biotech company in a post-Covid future, and more.
Moderna Jumps After Unexpectedly Reporting Profit In The First Quarter
09:19am, Thursday, 04'th May 2023
Moderna stock advanced Thursday after the company reported unexpected profit in the first quarter and beat sales expectations. The post Moderna Jumps After Unexpectedly Reporting Profit In The First Q
